Browse treatments

…). Treatment provision varied: 88% of the severe group received CPAP, 69% of moderate and 31% of mild; 29% of the mild group receive…

…ce were invited to complete a questionnaire prior to commencing CPAP treatment (Oct 2023-Mar 2024). Four domains were evaluated: severity of O…

…Introduction The 2024 BTS, NICE, SIGN asthma guidelines endorse anti-inflammatory-based management for everyone aged 12 years and over that are newly diagnosed or…

…hese. Although many were confident of the beneficial effects of homemade remedies, none were substituting them for prescribed medicines. Most par…

… healthcare costs. Despite improved specialist services, better ICS/LABA therapies and targeted monoclonal antibodies, it’s unknown if ICU admissi…

…ents across the UK, unknown to secondary care, are eligible for asthma biologic therapy. 1 This includes underserved populations who are at risk of poo…

…ainees felt completely unprepared before performing their first seldinger chest drain, while 61.8% (21/34) and 57.1% (24/42) of respiratory trainees …

…ollowed by chest drainage and 568/2592(21.9%) were treated with conservative care alone. The main reason of treatment was size of pneumothorax (2…

…gnosed with sarcoidosis on wedge lung biopsy after inconclusive EBUS-TBNA, and one patient was treated as sarcoidosis after a multidiscip…

…is series had received previous intravenous chemotherapy and/or intra-arterial chemotherapy. Patients received intravitreal topotecan (30 µg/0.1 mL) and/or…

…e 2 inflammation (screening blood eosinophils ≥300 cells/µL) on triple therapy. Patients received dupilumab 300 mg or placebo q2w for 52 weeks…

…ifferences relate to baseline clinical features and response to anti-IL5R therapy is an area of ongoing investigation.…